Biliary diseases are the most important medical and social problem associated with a high prevalence among working age population and a significant decrease in patients’ quality of life. Modern therapy methods, including the latest advances in medical science, have sustained significant progress in the treatment of biliary pathology. The design and introduction into clinical practice of the original drug Phosphogliv URSO has become an important step in making progress in this direction.